The FDA requires that all medications and medical devices must go through clinical trials before being put on the market. If a new treatment proves effective and safe in a study, it may become a new standard treatment.

Ochsner Health has partnered with the Multiple Myeloma Research Foundation to bring patients CureCloud ®, a research study with at-home genomic testing, which returns clinical results directly to patients and their physicians for treatment options.

Ochsner is committed to a multi-disciplinary, clinically-integrated research program of biomedical innovation and discovery with the ultimate goal of improving the health and wellness of our patients.

Ochsner offers several awards including: Ochsner Research Council Award for Outstanding Research by Trainees and The Alton Ochsner Award Relating Smoking and Disease.